Si-Bone (SIBN) Net Equity Issued and Repurchased (2020 - 2023)
Si-Bone (SIBN) posted Net Equity Issued and Repurchased of -$466000.0 for Q3 2023, down 100.65% on a QoQ basis from $71.6 million in Q4 2020.
Powered by 
Analysis
Si-Bone (SIBN) Net Equity Issued and Repurchased (2020 - 2023) Analysis & Trends
Si-Bone has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at -$466000.0 in Q3 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$466000.0 in Q3 2023; TTM through Dec 2024 was -$466000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $83.7 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was -$466000.0 for Q3 2023 at Si-Bone, down from $71.6 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $71.6 million in Q4 2020, with the low at -$466000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Si-Bone | 818.82 Mn | 672.88 Mn | 44.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -466,000.00 |
| Dec 31, 2020 | 71.64 Mn |
| Mar 31, 2020 | 62.98 Mn |